Venture capital firm
Emerson Collective portfolio
emersoncollective.comEmerson Collective is a venture capital firm based in Palo Alto, United States, founded in 2004. It has invested in 76 venture-backed companies across 104 funding rounds on VCMC, and led 14 of those rounds. 11 of them were in the last 12 months.
76
Venture-backed companies
in its portfolio on VCMC
104
Funding rounds
led 14
11
Last 12 months
rounds, Oct 2025 to Sep 2026
31
With a disclosed valuation
of 76 companies
$200.8B
Combined value of its private companies
the whole companies, not what Emerson Collective owns
70 private companies Emerson Collective has backed have a VCMC valuation; together they are worth $200.8B. That is the value of the whole companies, not what Emerson Collective owns. Ramp is 30% of the total. 6 companies it backed have since been acquired and are not included. How VCMC values companies.
Values cover private companies only; public companies are not included.
Portfolio
Emerson Collective's most valuable portfolio companies
The 10 most valuable private companies Emerson Collective has backed, by VCMC's valuation. Values cover private companies only; public companies are not included.
- 1 Ramp Tech Companies, New York $60.1B range $52.2B – $75.9B Joined at Growth, 2025
- 2 Deel Software Development Services, San Francisco $18.4B range $15.0B – $21.2B Led at Growth, 2022
- 3 Devoted Health Insurance - Agents, Carriers & Brokers, Eagan $18.0B range $11.5B – $20.8B Joined at Series D, 2021
- 4 Gusto Tech Companies, San Francisco $18.0B range $7.1B – $20.7B Joined at Series E, 2021
- 5 Commonwealth Fusion Systems Electric Supplies & Power Generation, Harvard $9.8B range $6.5B – $16.9B Joined at Series B, 2025
- 6 World Labs Tech Companies, San Francisco $7.0B range $4.3B – $9.5B Joined at Series B, 2026
- 7 Employment Agencies & HR Consulting, San Francisco $6.6B range $2.6B – $10.1B Joined at Series D, 2020
- 8 Redwood Materials Batteries, Carson City $6.5B range $5.2B – $7.7B Joined at Series C, 2021
- 9 Abridge Tech Companies, Philadelphia $6.2B range $4.6B – $8.2B Joined at Series E, 2026
- 10 Formation Bio Pharmaceutical Products, New York $6.0B range $1.5B – $8.5B Joined at Series D, 2024
Portfolio
Full Emerson Collective portfolio (76 companies)
76 companies. Load more shows the rest.
| # | Last round | History | Range | Trend | Grade | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Ramp Tech Companies · since Growth, 2025 | Growth Equity Oct 2026 $1.85B | $60.1B | $52.2B – $75.9B | $66.0B (+10%) | $5.9B | 0% | 6,282 | growing | A | |
| 2 | Redwood Materials Batteries · since Series C, 2021 | Series E Jan 2026 $425M | $6.5B | $5.2B – $7.7B | $6.0B (-8%) | $844M | 54% | 760 | flat | A | |
| 3 | Devoted Health Insurance - Agents, Carriers & Brokers · since Series D, 2021 | Series F Nov 2025 $48M | $18.0B | $11.5B – $20.8B | $18.1B (+1%) | $2.0B | 0% | 2,371 | up | A | |
| 4 | Commonwealth Fusion Systems Electric Supplies & Power Generation · since Series B, 2025 | Series C Jul 2026 $1.00B | $9.8B | $6.5B – $16.9B | $11.9B (+22%) | $1.3B | 0% | 1,114 | flat | B | |
| 5 | ElevateBio Pharmaceutical Products · since Series C, 2021 | Series D May 2023 $401M | $2.4B | $693M – $9.9B | $1.7B (-30%) | $720M | 79% | 450 | down | D | |
| 6 | World Labs Tech Companies · since Series B, 2026 | Series B Feb 2026 $1.00B | $7.0B | $4.3B – $9.5B | $8.3B (+18%) | $911M | 0% | 105 | growing | B | |
| 7 | Deel Software Development Services · led at Growth, 2022 | Series E Oct 2025 $300M | $18.4B | $15.0B – $21.2B | $15.1B (-18%) | $2.6B | 81% | 9,646 | flat | A | |
| 8 | Antora Batteries · since Series B, 2024 | Series C Jul 2026 $550M | $2.6B | $2.1B – $3.7B | $3.2B (+23%) | $355M | 0% | 273 | growing | A | |
| 9 | Abridge Tech Companies · since Series E, 2026 | Series E Apr 2026 $316M | $6.2B | $4.6B – $8.2B | $7.1B (+14%) | $780M | 0% | 677 | growing | A | |
| 10 | Carbon Industrial Machinery & Supplies · since Series D, 2017 | Growth Equity Nov 2025 $60M | $692M | $435M – $1.1B | $584M (-16%) | $65.6M | 51% | 518 | flat | B | |
| 11 | Arsenal Bio Biotechnology · since Series B, 2022 | Series C Sep 2024 $325M | $1.6B | $918M – $3.4B | $826M (-47%) | $368M | 97% | 168 | shrinking | C | |
| 12 | Gusto Tech Companies · since Series E, 2021 | Series E Aug 2021 $175M | $18.0B | $7.1B – $20.7B | $18.0B (0%) | $2.0B | 0% | 8,228 | growing | B | |
| 13 | Guild Professional & Management Training · since Series D, 2019 | Series F Jun 2022 $175M | $3.0B | $488M – $5.8B | $2.6B (-12%) | $608M | 33% | 1,196 | flat | D | |
| 14 | Formation Bio Pharmaceutical Products · since Series D, 2024 | Series D Jun 2024 $372M | $6.0B | $1.5B – $8.5B | $4.0B (-34%) | $660M | 0% | 198 | flat | C | |
| 15 | Aurora Solar Tech Companies · since Series D, 2022 | Series D Feb 2022 $200M | $772M | $306M – $6.0B | $720M (-7%) | $580M | 97% | 299 | down | D | |
| 16 | Tech Companies · since Series C, 2021 | Series C Mar 2021 $150M | $499M | $156M – $3.3B | $451M (-10%) | $257M | 97% | 409 | down | D | |
| 17 | Tech Companies · since Series C, 2024 | Series C Feb 2024 $100M | $2.6B | $1.2B – $3.0B | $2.1B (-19%) | $284M | 0% | 643 | up | B | |
| 18 | Tech Companies · since Series D, 2024 | Series D Apr 2024 $60M | $1.1B | $439M – $1.6B | $1.0B (-13%) | $126M | 0% | 1,953 | up | C | |
| 19 | Basketball Club · since Growth, 2022 | Other Jun 2025 $21M | $1.4B | $200M – $1.6B | $1.3B (-2%) | $127M | 0% | 275 | up | D | |
| 20 | Tech Companies · since Series C, 2021 | Series C Feb 2021 $55M | $798M | $68.0M – $975M | $784M (-2%) | $119M | 0% | 525 | flat | D | |
| 21 | Tech Companies · since Series B, 2022 | Growth Equity Dec 2024 $28M | $220M | $124M – $439M | $145M (-34%) | $29.3M | 97% | 72 | down | C | |
| 22 | Tech Companies · since Growth, 2021 | Growth Equity Jun 2021 $70M | $518M | $89.9M – $2.0B | $452M (-13%) | $135M | 59% | 26 | flat | D | |
| 23 | Tech Companies · since Series A, 2022 | Series B May 2024 $33M | $401M | $137M – $569M | $344M (-14%) | $44.1M | 0% | 88 | up | C | |
| 24 | Medical Supply Manufacturers · since Series A, 2026 | Series A Jul 2026 $10M | $64.3M | $39.3M – $142M | $100M (+56%) | $14.1M | 0% | 27 | growing | C | |
| 25 | Tech Companies · since Series B, 2020 | Series B Oct 2020 $14M | $62.3M | $7.22M – $168M | $57.3M (-8%) | $18.1M | 37% | 139 | flat | D | |
| 26 | Electronical Components Manufacturing · since Seed, 2022 | Seed Feb 2022 $9.3M | $0.48M | $0 – $0.48M | $0.48M (0%) | – | 100% | 19 | flat | dead | |
| 27 | Tech Companies · since Seed, 2023 | Grant Apr 2026 $4.0M | $52.3M | $3.77M – $79.7M | $52.3M (0%) | $7.92M | 0% | 55 | unknown | D | |
| 28 | Food Banks · since Seed, 2016 | Seed Mar 2016 $3.1M | $17.8M | $0.81M – $36.6M | $17.2M (-3%) | $4.46M | 15% | 120 | flat | D | |
| 29 | Tech Companies · since Seed, 2023 | Acquisition Sep 2025 | $66.0M acquired 2025 | $7.85M – $132M | – | – | 0% | 19 | up | D | |
| 30 | Tech Companies · since Growth, 2025 | Growth Equity Aug 2025 $405M | $5.1B | $3.2B – $7.2B | $5.1B (0%) | $456M | 0% | 346 | growing | B | |
| 31 | Employment Agencies & HR Consulting · since Series D, 2020 | Series F Jan 2022 $200M | $6.6B | $2.6B – $10.1B | $6.6B (0%) | $962M | 0% | 11,879 | growing | C | |
| 32 | Medical Laboratories · since Series B, 2016 | Series E Nov 2021 $100M | $3.2B | $251M – $5.9B | $3.0B (-6%) | $652M | 0% | 652 | flat | D | |
| 33 | Pharmaceutical Products · since Series B, 2021 | Series C Jan 2025 $100M | $908M | $450M – $1.1B | $825M (-9%) | $114M | 29% | 200 | unknown | B | |
| 34 | Tech Companies · since Series B, 2018 | Acquisition Jun 2026 $4.17B | $1.8B acquired 2026 | $317M – $2.5B | – | – | 11% | 624 | up | D | |
| 35 | Research Institutes · since Series D, 2024 | Series D Oct 2024 $130M | $1.7B | $598M – $2.8B | $1.1B (-39%) | $227M | 30% | 151 | flat | C | |
| 36 | Biotechnology · since Series B, 2021 | Series C Jan 2023 $100M | $203M | $102M – $775M | $124M (-39%) | $133M | 97% | 54 | shrinking | D | |
| 37 | Solar Energy Company · led at Series D, 2021 | Debt Aug 2023 $12M | $158M | $77.2M – $480M | $156M (-1%) | $106M | 97% | 330 | shrinking | C | |
| 38 | Health Care Services · led at Seed, 2022 | Series D Feb 2026 $100M | $1.2B | $869M – $1.6B | $1.4B (+9%) | $150M | 0% | 795 | growing | A | |
| 39 | Aerospace and Defence · since Series C, 2021 | Growth Equity May 2025 $60M | $746M | $341M – $1.1B | $743M (0%) | $67.3M | 1% | 262 | flat | C | |
| 40 | Professional & Management Training · since Series D, 2015 | Acquisition May 2024 | $1.0B acquired 2024 | $86.9M – $1.2B | – | – | 0% | 4,300 | flat | D | |
| 41 | Tech Companies · since Series A, 2026 | Series A Aug 2026 $150M | $1.2B | $913M – $2.2B | $1.9B (+64%) | $266M | 0% | 57 | growing | B | |
| 42 | Educational Consultants · since Series B, 2021 | Series C May 2023 | $1.7B | $163M – $3.5B | $1.6B (-8%) | $198M | 0% | 3,102 | flat | D | |
| 43 | Biotechnology · led at Growth, 2021 | Series B Jan 2025 $175M | $844M | $470M – $1.8B | $527M (-38%) | $188M | 97% | 63 | shrinking | C | |
| 44 | Biotechnology · since Growth, 2023 | Growth Equity Aug 2023 $200M | $1.2B | $265M – $3.5B | $1.0B (-14%) | $223M | 31% | 49 | flat | D | |
| 45 | Food Production · led at Series B, 2017 | Series E Mar 2022 $85M | $561M | $62.4M – $1.5B | $511M (-9%) | $133M | 26% | 85 | flat | D | |
| 46 | Biotechnology · since Series A, 2024 | Series B Aug 2026 $77M | $1.0B | $826M – $1.6B | $1.4B (+38%) | $157M | 0% | 62 | up | B | |
| 47 | Electric Supplies & Power Generation · since Series A, 2024 | Grant Oct 2026 $31M | $1.3B | $488M – $2.0B | $931M (-28%) | $182M | 0% | 167 | growing | C | |
| 48 | Medical Supply Manufacturers · since Series C, 2019 | Acquisition Jul 2023 $1.30B | $791M acquired 2023 | $539M – $927M | – | – | 0% | 290 | growing | A | |
| 49 | Tech Companies · since Series C, 2022 | Series C Jun 2022 $80M | $462M | $69.7M – $1.0B | $439M (-5%) | $92.2M | 8% | 123 | up | D | |
| 50 | Rehab & Addiction - Centers & Therapists · since Series D, 2024 | Series D Oct 2024 $30M | $327M | $127M – $662M | $203M (-38%) | $51.7M | 63% | 153 | flat | C |
Valuation: VCMC's valuation with its range, from a low to a high scenario; a company with no valuation shows a dash, one acquired after its last round its last value as a private company.
Activity
How Emerson Collective invests: stages, industries and countries
Most of its rounds are Series C and later (43%). Its companies span 29 industries, most in Tech Companies, Biotechnology and Batteries, across 4 countries.
Rounds by stage
- Pre-seed 1
- Seed 13
- Series A 20
- Series B 23
- Series C and later 45
- Other venture 2
Investments by industry
- Tech Companies 27
- Biotechnology 7
- Batteries 4
- Professional & Management Training 4
- Medical Supply Manufacturers 3
- Pharmaceutical Products 3
- Educational Consultants 2
- Electric Supplies & Power Generation 2
Investments by country
- United States 72
- Norway 2
- Iceland 1
- United Kingdom 1
Recent rounds
Emerson Collective's latest investments
Emerson Collective's most recent funding rounds, newest first. 11 rounds in the last 12 months.
- Series A $22M 22 Sep 2026
- Series A $150M 25 Aug 2026
- Series B $77M 13 Aug 2026
- Series A $10M 28 Jul 2026
- Series A $64M 19 May 2026
- Growth $46M 12 May 2026
- Abridge Series E $316M 1 Apr 2026
- World Labs Series B $1.00B 18 Feb 2026
- Series D $100M 3 Feb 2026
- Ramp Growth $300M 17 Nov 2025
Co-investors
Emerson Collective's top co-investors
The investors that most often join the same rounds as Emerson Collective. General Catalyst leads, with 12 rounds together.
- General Catalyst 12 rounds together
- Andreessen Horowitz 10 rounds together
- Bessemer Venture Partners 8 rounds together
- Salesforce Ventures 7 rounds together
- Kleiner Perkins 7 rounds together
- Breakthrough Energy 7 rounds together
- Sequoia Capital 6 rounds together
- SoftBank Vision Fund 6 rounds together
- GV 6 rounds together
- Khosla Ventures 6 rounds together
About
About Emerson Collective
Emerson Collective, LLC is an American limited liability company that operates as a venture capital firm, philanthropic organization, and educational initiative provider. The company invests in entrepreneurs and nonprofits, supports companies addressing social and environmental challenges, and engages in advocacy and community engagement. Emerson Collective also publishes articles on topics such as fossil fuels and environmental impact, and organizes events to showcase innovative solutions.
Description from Veridion's company data.
- Founded
- 2004
- Based in
- Palo Alto, United States
- Team
- 245 people, -12% in a year
- Type
- Venture capital firm
Focus markets
- Education
- Economic Mobility
- Immigration
- Environment
- Media and Journalism
- Health
What Emerson Collective offers
- Venture Capital Investment Services
- Entrepreneur and Innovator Partnership Services
- High School Education Transformation Services
- Advocacy Campaign Execution
Questions
Emerson Collective: frequently asked questions
How many companies has Emerson Collective invested in?
76 venture-backed companies on VCMC, across 104 funding rounds.
What are Emerson Collective's most valuable private companies?
Ramp ($60.1B), Deel ($18.4B), Devoted Health ($18.0B), by VCMC's valuation.
What was Emerson Collective's latest investment?
Teal Health, a Series A round in Sep 2026 of $22M.
Which stages does Emerson Collective invest in?
Emerson Collective invests most often at Series C and later (45 rounds), followed by Series B (23) and Series A (20). It has also joined 13 seed, 2 other venture and 1 pre-seed rounds.
What is Emerson Collective's portfolio worth?
Its private companies with a VCMC valuation are worth $200.8B together. That is the sum of the companies' values, not what Emerson Collective owns.
Who does Emerson Collective invest alongside?
General Catalyst (12 rounds), Andreessen Horowitz (10 rounds), Bessemer Venture Partners (8 rounds).